/* Hide scrollbar for Chrome, Safari and Opera */
.hide-scrollbar::-webkit-scrollbar {
display: none;
}
.hide-scrollbar::-webkit-scrollbar {
display: none;
}
/* Hide scrollbar for IE, Edge and Firefox */
.hide-scrollbar {
-ms-overflow-style: none; /* IE and Edge */
scrollbar-width: none; /* Firefox */
}
Video content above is prompted by the following:
- Which patients are ideal candidates for this anti-VEGF delivery method?
- Patients with frequent anti-VEGF treatment burden (4-8 weeks)
Leave a Reply